Startups
Alto Neuroscience
Mountain View, California, United States
Alto Neuroscience, Inc. is a publicly listed, clinical-stage biopharmaceutical company developing precision treatments for neuropsychiatric disorders. Founded in 2019 by psychiatrist and neuroscientist Amit Etkin, its machine learning platform combines EEG brain activity, computerized cognition tests, wearable sleep and activity data, and clinical datasets to identify patient groups more likely to respond to particular drug candidates. Its investigational pipeline addresses major depressive disorder, treatment-resistant depression, bipolar depression and schizophrenia. The platform supports biomarker selection and drug development; the company’s candidates remain investigational. Alto completed its NYSE ANRO initial public offering in February 2024, followed by institutional private placements and a July 2026 registered direct offering. It is headquartered in Mountain View, California.
Founded 2019
Team
 Adam SavitzChief Medical Officer |
 Alan SchatzbergScientific Advisor |
 Amit EtkinFounder and Chief Executive Officer · Chair of the Board |
 Andrew DreyfusBoard Director |
 Andrew MillerBoard Director |
 Christopher MartinVice President, CMC Operations (published May 2026) |
 Christopher Nixon CoxBoard Director |
 Dan SegalCo-founder and Strategic Advisor |
 Erin R. McQuadeGeneral Counsel and Chief Administrative Officer |
 Gwill YorkBoard Director |
 Husseini ManjiBoard Director |
 Jessica PowellChief Development Officer |
 Jill SniffenVice President, Clinical Operations (published May 2026) |
 Jonathon ParkerSenior Vice President, Head of Regulatory Affairs (published May 2026) |
 Madhukar H. TrivediScientific Advisor |
 Melissa BermanVice President, Finance and Accounting, and Controller (published May 2026) |
 Michael HanleyChief Operating Officer |
 Michelle MoranVice President, Quality Assurance (published May 2026) |
 Nick Smith (Alto Neuroscience)President and Chief Financial Officer |
 Patricio O’DonnellVice President, Translational Medicine (published May 2026) |
 Quentin HuysScientific Advisor |
 Raymond SanchezBoard Director |
 Tom InselScientific Advisor |